Dr. Leena Gandhi is the director of the Center for Cancer Therapeutic Innovation, a cross-malignancy novel therapeutics hub, at the Dana-Farber Cancer Institute.
She has spent her career taking care of lung cancer patients and running clinical trials. Her research is focused on understanding how and why patients respond to therapy by evaluating certain markersgenetic changes, proteins, and other featuresin blood or tumor tissue.
